articleEPR's inaugural Pharma Horizons report explores the latest advances in…
24 January 2024 | By European Pharmaceutical Review
EPR's inaugural Pharma Horizons report explores the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control.